Literature DB >> 34952835

Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID： 34952835     DOI： 10.1136/bmj.n3151

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

Review 1.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

2.  Estimating the Nosocomial Transmission Rate of COVID-19 in Orthopaedic Surgery Patients During the Peak of the Pandemic.

Authors:  Anna H Green; Julianne M Forlizzi; Joseph Boyle; Wilfrido J Castillo; Daniel Mascarenhas; Meizhen Yao; Geza Kiss; Carlos Sagebien
Journal:  Orthop Res Rev       Date:  2022-06-18

3.  SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.

Authors:  Jessica Taytard; Blandine Prevost; Aurélie Schnuriger; Guillaume Aubertin; Laura Berdah; Lauren Bitton; Audrey Dupond-Athenor; Guillaume Thouvenin; Nadia Nathan; Harriet Corvol
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

Review 4.  Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.

Authors:  Ranjan Ramasamy
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

Review 5.  Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection.

Authors:  Endeshaw Chekol Abebe; Markeshaw Tiruneh G/Medhin; Awgichew Behaile T/Mariam; Tadesse Asmamaw Dejenie; Teklie Mengie Ayele; Fitalew Tadele Admasu; Zelalem Tilahun Muche; Getachew Asmare Adela
Journal:  Infect Drug Resist       Date:  2022-04-15       Impact factor: 4.177

Review 6.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

7.  [Reinfection by the Omicron variant in patients previously infected with the Delta variant of the SARS-CoV-2 coronavirus: An increasingly frequent reality in Primary Care].

Authors:  N Sánchez-Varela; S Cinza-Sanjurjo; M Portela-Romero
Journal:  Semergen       Date:  2022-01-14

Review 8.  SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants.

Authors:  Almu'atasim Khamees; Jamal Bani-Issa; Mazhar Salim Al Zoubi; Taqwa Qasem; Manal Issam AbuAlArjah; Sura Ahmad Alawadin; Khayry Al-Shami; Farah E Hussein; Emad Hussein; Ibrahim H Bashayreh; Murtaza M Tambuwala; Mohannad Al-Saghir; Christopher T Cornelison
Journal:  Pathogens       Date:  2022-02-20

Review 9.  Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.

Authors:  Giorgio Tiecco; Samuele Storti; Melania Degli Antoni; Emanuele Focà; Francesco Castelli; Eugenia Quiros-Roldan
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

Review 10.  Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy.

Authors:  Amirmasoud Rayati Damavandi; Razieh Dowran; Sarah Al Sharif; Fatah Kashanchi; Reza Jafari
Journal:  Med Microbiol Immunol       Date:  2022-03-02       Impact factor: 4.148
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.